About this Research Topic
With increasing cutting-edge techniques applied in the field of cardiothoracic surgery, conventional surgical treatment and perioperative management of patients with thoracic malignancy has been facing more and more challenges. Meanwhile, with the prevalence of multidisciplinary team in treating thoracic cancer, the roles of therapeutic methods in addition to surgical resection, such as radiation, targeted therapy and immunotherapy, have captured clinicians' attention. Therefore, it is essential to identify more promising therapeutic targets and to provide more evidence-based treatment strategies in the era of precision medicine.
The goals of this Research Topic are:
1. How to improve the clinical outcomes of surgical patients in the context of increasing therapeutic targets and prognostic factors?
2. How to identify potential candidates who might benefit from adjuvant therapy?
3. How to address the controversy concerning different surgical procedures or approaches towards thoracic cancer?
4. How to overcome the limitations of the current edition TNM staging system in thoracic cancer?
This Topic invites manuscripts inclusive of all malignant thoracic disease that encompass the chest, the chest wall, the lung, esophagus, and mediastinum. The following article types are potentially acceptable for the Topic:
• Phase I trials
• Well performed single-arm phase II trials
• Subset analyses of published trials
• Impactful retrospective Studies
• Database analysis
• Large institutional series
• Subspecialty thoracic oncology studies
• High-quality systematic review and meta-analysis
Keywords: Thoracic Cancer, Surgery, Precision Medicine, Multidisciplinary, Outcomes
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.